Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Faculty of Medicine, Ogarev Mordovia State University, Saransk, Russia.
Langenbecks Arch Surg. 2024 Jul 4;409(1):204. doi: 10.1007/s00423-024-03377-x.
Our study aimed to compare the effectiveness and complications of the transoral endoscopic thyroidectomy submental vestibular approach (TOETSMVA) versus the transoral endoscopic thyroidectomy vestibular approach (TOETVA) or conventional open thyroidectomy (COT) in patients with early-stage papillary thyroid carcinoma (PTC).
We searched online databases up to January 2024. The outcomes were analyzed using RevMan 5.4 and inverse variance.
Seven studies (two RCTs and five retrospective cohort studies) were included. We established higher significance differences for TOETSMVA in comparison with TOETVA in terms of all primary outcomes; operation time, hospital stay, number of resected lymph nodes [MD -21.05, 95% CI= -30.98, -11.12; p < 0.0001], [MD -1.76, 95% CI= -2.21, -1.32, p < 0.00001], [MD -2.99, 95% CI= -19.75, 13.76, p < 0.73], [MD -0.83, 95% CI = -1.19 to -0.47; p < 0.00001], respectively, except the drainage volume, it showed no difference [MD -2.99, 95% CI= -19.75, 13.76, p < 0.73]. In secondary outcomes, it was favored only in mandibular numbness and return to normal diet outcomes. Additionally, TOETSMVA compared with COT showed a significant difference in drainage volume, pain, cosmetic effect, and satisfaction score.
TOETSMVA showed a significant improvement compared to the TOETVA in operation time, hospital stay, number of resected lymph nodes, mandibular numbness, and return to normal diet but did not show a difference in drainage volume. However, TOETSMVA was better in cosmetic effect, drainage volume, satisfaction, and pain scores compared with COT. Further RCTs with larger sample size, multicentral, and longer follow-up are necessary to evaluate the limitations.
本研究旨在比较经口内镜下甲状腺切除术颏下入路(TOETSMVA)与经口内镜下甲状腺切除术前庭入路(TOETVA)或传统开放甲状腺切除术(COT)在早期甲状腺乳头状癌(PTC)患者中的有效性和并发症。
我们检索了截至 2024 年 1 月的在线数据库。使用 RevMan 5.4 和逆方差法分析结果。
纳入 7 项研究(2 项 RCT 和 5 项回顾性队列研究)。与 TOETVA 相比,TOETSMVA 在所有主要结局方面都具有更高的显著性差异;手术时间、住院时间、切除淋巴结数量[MD-21.05,95%CI=-30.98,-11.12;p<0.0001]、[MD-1.76,95%CI=-2.21,-1.32,p<0.00001]、[MD-2.99,95%CI=-19.75,13.76,p<0.73]、[MD-0.83,95%CI=-1.19 至-0.47;p<0.00001],但引流量无差异[MD-2.99,95%CI=-19.75,13.76,p<0.73]。在次要结局方面,仅在颏下麻木和恢复正常饮食方面有优势。此外,与 COT 相比,TOETSMVA 在引流量、疼痛、美容效果和满意度评分方面也有显著差异。
与 TOETVA 相比,TOETSMVA 在手术时间、住院时间、切除淋巴结数量、颏下麻木和恢复正常饮食方面有显著改善,但在引流量方面无差异。然而,与 COT 相比,TOETSMVA 在美容效果、引流量、满意度和疼痛评分方面更具优势。需要进一步开展具有更大样本量、多中心和更长随访时间的 RCT 来评估其局限性。